Antibody-Drug Conjugates in Bladder Cancer

Urothelial carcinoma (UC) is characterized by expression of a plethora of cell surface antigens, thus offering opportunities for specific therapeutic targeting with use of antibody-drug conjugates (ADCs). ADCs are structured from two major constituents, a monoclonal antibody (mAb) against a specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Vlachostergios, Panagiotis J., Jakubowski, Christopher D., Niaz, Muhammad J., Lee, Aileen, Thomas, Charlene, Hackett, Amy L., Patel, Priyanka, Rashid, Naureen, Tagawa, Scott T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087439/
https://www.ncbi.nlm.nih.gov/pubmed/30112436
http://dx.doi.org/10.3233/BLC-180169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087439/
https://www.ncbi.nlm.nih.gov/pubmed/30112436
http://dx.doi.org/10.3233/BLC-180169

Ejemplares similares